Balyasny Asset Management
DSCI

Balyasny Asset Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Balyasny Asset Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-23,880
Closed -$109K – 1751
2015
Q4 		$109K Buy
+23,880
New +$113K ﹤0.01% 1159

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Balyasny Asset Management's DSCI Position: Q1 2016 in Review

Balyasny Asset Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2016, closing a stake of 23,880 shares — an estimated $109K sold.

Balyasny Asset Management first reported a position in DSCI in Q4 2015 and held it in 1 quarter. The position peaked at $109K in Q4 2015. 55 funds tracked by Wall St. Rank hold DSCI as of Q1 2016.

  • Balyasny Asset Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2016 after selling out during the quarter.
  • Balyasny Asset Management sold 23,880 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2016, an estimated $109K.
  • Balyasny Asset Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2015 and held it in 1 quarter.
  • Balyasny Asset Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $109K in Q4 2015.
  • 55 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2016.

Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.